These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 36668815)
1. Amorphous Drug-Polymer Salts: Maximizing Proton Transfer to Enhance Stability and Release. Neusaenger AL; Yao X; Yu J; Kim S; Hui HW; Huang L; Que C; Yu L Mol Pharm; 2023 Feb; 20(2):1347-1356. PubMed ID: 36668815 [TBL] [Abstract][Full Text] [Related]
2. Amorphous Drug-Polymer Salt with High Stability under Tropical Conditions and Fast Dissolution: The Challenging Case of Lumefantrine-PAA. Yao X; Kim S; Gui Y; Chen Z; Yu J; Jones KJ; Yu L J Pharm Sci; 2021 Nov; 110(11):3670-3677. PubMed ID: 34371071 [TBL] [Abstract][Full Text] [Related]
3. Amorphous Drug-Polymer Salt with High Stability under Tropical Conditions and Fast Dissolution: The Case of Clofazimine and Poly(acrylic acid). Gui Y; McCann EC; Yao X; Li Y; Jones KJ; Yu L Mol Pharm; 2021 Mar; 18(3):1364-1372. PubMed ID: 33522821 [TBL] [Abstract][Full Text] [Related]
4. Effect of Polymer Architecture and Acidic Group Density on the Degree of Salt Formation in Amorphous Solid Dispersions. Neusaenger AL; Fatina C; Yu J; Yu L Mol Pharm; 2024 Jul; 21(7):3375-3382. PubMed ID: 38885189 [TBL] [Abstract][Full Text] [Related]
5. Combining drug salt formation with amorphous solid dispersions - a double edged sword. Hiew TN; Taylor LS J Control Release; 2022 Dec; 352():47-60. PubMed ID: 36206947 [TBL] [Abstract][Full Text] [Related]
6. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization. Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284 [TBL] [Abstract][Full Text] [Related]
7. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion. Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138 [TBL] [Abstract][Full Text] [Related]
8. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion. Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685 [TBL] [Abstract][Full Text] [Related]
9. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions. Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425 [TBL] [Abstract][Full Text] [Related]
10. Balancing Solid-State Stability and Dissolution Performance of Lumefantrine Amorphous Solid Dispersions: The Role of Polymer Choice and Drug-Polymer Interactions. Hiew TN; Zemlyanov DY; Taylor LS Mol Pharm; 2022 Feb; 19(2):392-413. PubMed ID: 34494842 [TBL] [Abstract][Full Text] [Related]
11. Physical stability and release properties of lumefantrine amorphous solid dispersion granules prepared by a simple solvent evaporation approach. Trasi NS; Bhujbal SV; Zemlyanov DY; Zhou QT; Taylor LS Int J Pharm X; 2020 Dec; 2():100052. PubMed ID: 32760909 [TBL] [Abstract][Full Text] [Related]
12. Acid-base interactions in amorphous solid dispersions of lumefantrine prepared by spray-drying and hot-melt extrusion using X-ray photoelectron spectroscopy. Song Y; Zemlyanov D; Chen X; Su Z; Nie H; Lubach JW; Smith D; Byrn S; Pinal R Int J Pharm; 2016 Dec; 514(2):456-464. PubMed ID: 27370910 [TBL] [Abstract][Full Text] [Related]
13. Molecular implications of drug-polymer solubility in understanding the destabilization of solid dispersions by milling. Yang Z; Nollenberger K; Albers J; Qi S Mol Pharm; 2014 Jul; 11(7):2453-65. PubMed ID: 24897345 [TBL] [Abstract][Full Text] [Related]
15. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying. Tian Y; Caron V; Jones DS; Healy AM; Andrews GP J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445 [TBL] [Abstract][Full Text] [Related]
16. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions. Guo Z; Lu M; Li Y; Pang H; Lin L; Liu X; Wu C J Pharm Pharmacol; 2014 Feb; 66(2):285-96. PubMed ID: 24433427 [TBL] [Abstract][Full Text] [Related]
17. A systematic and robust assessment of hot-melt extrusion-based amorphous solid dispersions: Theoretical prediction to practical implementation. Alzahrani A; Nyavanandi D; Mandati P; Youssef AAA; Narala S; Bandari S; Repka M Int J Pharm; 2022 Aug; 624():121951. PubMed ID: 35753536 [TBL] [Abstract][Full Text] [Related]
18. Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier. Xu M; Zhang C; Luo Y; Xu L; Tao X; Wang Y; He H; Tang X Drug Dev Ind Pharm; 2014 Jan; 40(1):126-35. PubMed ID: 23336809 [TBL] [Abstract][Full Text] [Related]
19. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole. Sarpal K; Tower CW; Munson EJ Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316 [TBL] [Abstract][Full Text] [Related]
20. Reactive Melt Extrusion To Improve the Dissolution Performance and Physical Stability of Naproxen Amorphous Solid Dispersions. Liu X; Zhou L; Zhang F Mol Pharm; 2017 Mar; 14(3):658-673. PubMed ID: 28135108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]